CUHP’s mission renewed for five more years
Cambridge University Health Partners (CUHP) has successfully been re-designated as a National Institute for Health Research – NHS England/Improvement (NIHR-NHSE/I) Academic Health Sciences Centre (AHSC) for a further five years.
The organisation was able to demonstrate (CUHP Impact Review 2018/19) an excellence in research, patient care and health education as well as a capacity for translating scientific advances into patient benefit in its application and panel interview.
Based on the Cambridge Biomedical Campus, CUHP will now continue its mission to bring together its members: the University of Cambridge, Cambridge and Peterborough NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust and Royal Papworth Hospital NHS Foundation Trust to improve patient healthcare through collaboration by the NHS, industry and academia.
CUHP will concentrate on six disease areas which have demonstrated a demand for new, improved prevention and treatment and where the four partners have world-leading expertise:
- tackling obesity and diabetes
- infection and immune system research
- heart and lung disease
- dementia and nervous system disorders
- mental health.
Laurel Powers-Freeling, Chair of Cambridge University Health Partners, said: “We are very proud to have received our re-designation this week as an Academic Health Sciences Centre, demonstrating that Cambridge University Health Partners (CUHP) had not only delivered since our inception in 2009 but that we had a strong strategic plan moving forward. Our partners have together committed to make a significant improvement to the health and wealth of our local population, while also addressing serious health challenges across the world – this is our five year mission.
“It helps significantly that we are based on the Cambridge Biomedical Campus, which is at the forefront of the changing face of healthcare, with thousands of researchers and clinicians focusing on prevention, early diagnosis and new treatments for patients. This work is all the more important given the impact of the Coronavirus (COVID-19) outbreak and the need for the life sciences industry to rapidly deliver innovative solutions and treatments.
“We are living through unprecedented times, making the collaboration we have fostered over the recent years all the more important. CUHP are focusing all our resources and expertise on overcoming the COVID-19 pandemic, working together across disciplines and organisations to support health and care delivery and to trial new diagnostics and treatments for the disease.”